The big AI labs' safety push could come with a competitive advantage

Here is a sentence to file under Things We Were Told Would Be Free: the safety push at the big AI labs might be a competitive advantage. PitchBook senior analyst Harrison Rolfes calls the recent wave of safety announcements — and the executives' solemn calls for slowing model development — what it is: AI safety 'theater.' A trifle unfair to theater, that; theater at least has rehearsals, a script, and a curtain that comes down. What we have instead is the 'tapping the brakes' conversation we noted recently, now with a sponsorship deal attached. The only thing genuinely being slowed down, presumably, is whichever competitor misses the announcement.

The proposed architecture is delicious. Big labs would jointly agree to let independent evaluation firms — METR, Redwood Research and Apollo Research — test their frontier models. Three firms, refereeing a league in which every player is also a prospective client, deciding what counts as safe and then invoicing someone for the privilege. Anthropic CEO Dario Amodei's essay goes further, proposing independent safety evaluators embedded inside the companies themselves, which is a lovely idea in the same way that having your landlord live in your spare room is a lovely idea. Independence, in this arrangement, is a job title.

So the theater isn't theater. It's marketing with a lab coat on: the model that ships with a third-party audit gets the enterprise contract, the government cheque, the reassuring board deck. The labs that shout loudest about pausing are, conveniently, the ones who can afford the pause. Everyone else will be told the playing field is level; it is a moat with a published methodology and nobody holding the authority to say no. Rolfes reached for the word 'theater.' Give it a season and it'll be 'infrastructure.'